|
US4369184A
(en)
|
1980-01-24 |
1983-01-18 |
Janssen Pharmaceutica N.V. |
1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives
|
|
JPS56110674A
(en)
|
1980-01-24 |
1981-09-01 |
Janssen Pharmaceutica Nv |
Novel 11*cyclohexyl**44aryll44piperidine carboxylic acid derivative
|
|
US5852029A
(en)
|
1990-04-10 |
1998-12-22 |
Israel Institute For Biological Research |
Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
|
|
GB9300194D0
(en)
|
1993-01-06 |
1993-03-03 |
Wyeth John & Brother Ltd |
Piperazine derivatives
|
|
US5446051A
(en)
|
1994-05-31 |
1995-08-29 |
Eli Lilly And Company |
Aryl-spaced decahydroisoquinoline-3-carboxylic acids as excitatory amino acid receptor antagonists
|
|
EP0786997A4
(en)
|
1994-10-27 |
1998-03-11 |
Merck & Co Inc |
MUSCARINE ANTAGONISTS
|
|
US5889006A
(en)
|
1995-02-23 |
1999-03-30 |
Schering Corporation |
Muscarinic antagonists
|
|
IL117149A0
(en)
|
1995-02-23 |
1996-06-18 |
Schering Corp |
Muscarinic antagonists
|
|
AU7478496A
(en)
|
1995-10-31 |
1997-05-22 |
Merck & Co., Inc. |
Muscarine antagonists
|
|
US5854245A
(en)
|
1996-06-28 |
1998-12-29 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
AU3632297A
(en)
|
1996-08-26 |
1998-03-19 |
Pfizer Inc. |
Spirocyclic dopamine receptor subtype ligands
|
|
WO1998057641A1
(en)
|
1997-06-18 |
1998-12-23 |
Merck & Co., Inc. |
ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
|
|
GB9715892D0
(en)
|
1997-07-29 |
1997-10-01 |
Zeneca Ltd |
Heterocyclic compounds
|
|
AU2095099A
(en)
|
1997-12-23 |
1999-07-12 |
Alcon Laboratories, Inc. |
Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparationand their use as muscarinic receptor (ant-)agonists
|
|
AU2307899A
(en)
|
1997-12-23 |
1999-07-12 |
Alcon Laboratories, Inc. |
Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
|
|
WO1999032489A1
(en)
|
1997-12-23 |
1999-07-01 |
Alcon Laboratories, Inc. |
Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
|
|
WO1999032481A1
(en)
|
1997-12-23 |
1999-07-01 |
Alcon Laboratories, Inc. |
Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
|
|
CZ286152B6
(cs)
|
1998-03-13 |
2000-01-12 |
Miroslav Ing. Csc. Vlček |
Transparentní a semitransparentní difrakční prvky
|
|
US6387930B1
(en)
|
1999-05-04 |
2002-05-14 |
Schering Corporation |
Piperidine derivatives useful as CCR5 antagonists
|
|
CZ301161B6
(cs)
|
1999-05-04 |
2009-11-18 |
Schering Corporation |
Piperidinopiperidylový derivát užitecný jako CCR5 antagonista, farmaceutický prostredek jej obsahující
|
|
PT1175224E
(pt)
|
1999-05-04 |
2005-07-29 |
Schering Corp |
Terapeutica de combinacao contra hiv com interferao-alfa peguilado e um antagonista de ccr5
|
|
US6420364B1
(en)
|
1999-09-13 |
2002-07-16 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compound useful as reversible inhibitors of cysteine proteases
|
|
NZ518255A
(en)
|
1999-09-13 |
2004-11-26 |
Boehringer Ingelheim Pharma |
Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
|
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
|
ES2223588T3
(es)
|
1999-10-13 |
2005-03-01 |
Banyu Pharmaceutical Co., Ltd. |
Derivados de imidazolidinona sustituidos.
|
|
US7163938B2
(en)
|
2000-11-28 |
2007-01-16 |
Eli Lilly And Company |
Substituted carboxamides
|
|
US7164024B2
(en)
|
2001-04-20 |
2007-01-16 |
Banyu Pharmaceutical Co., Ltd. |
Benzimidazolone derivatives
|
|
WO2002100399A1
(en)
|
2001-06-12 |
2002-12-19 |
Elan Pharmaceuticals, Inc. |
Macrocycles useful in the treatment of alzheimer's disease
|
|
WO2004089942A2
(en)
|
2001-10-02 |
2004-10-21 |
Acadia Pharmaceuticals Inc. |
Benzimidazolidinone derivatives as muscarinic agents
|
|
GB0128378D0
(en)
|
2001-11-27 |
2002-01-16 |
Smithkline Beecham Plc |
Novel Compounds
|
|
NZ533566A
(en)
|
2001-12-28 |
2007-03-30 |
Acadia Pharm Inc |
Tetrahydroquinoline analogues as muscarinic agonists
|
|
US7550459B2
(en)
|
2001-12-28 |
2009-06-23 |
Acadia Pharmaceuticals, Inc. |
Tetrahydroquinoline analogues as muscarinic agonists
|
|
US7256186B2
(en)
|
2002-02-06 |
2007-08-14 |
Schering Corporation |
Gamma secretase inhibitors
|
|
US20040171614A1
(en)
|
2002-02-06 |
2004-09-02 |
Schering-Plough Corporation |
Novel gamma secretase inhibitors
|
|
ATE454381T1
(de)
|
2002-03-28 |
2010-01-15 |
Mitsubishi Tanabe Pharma Corp |
Benzofuranderivat
|
|
AU2003242252A1
(en)
|
2002-06-07 |
2003-12-22 |
Kyowa Hakko Kogyo Co., Ltd. |
Bicyclic pyrimidine derivatives
|
|
WO2004014853A1
(en)
|
2002-07-31 |
2004-02-19 |
Ranbaxy Laboratories Limited |
3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
|
|
PT1551835E
(pt)
|
2002-09-30 |
2007-03-30 |
Neurosearch As |
Novos derivados de 1, 4-diazabicicloalcano, sua preparação e utilização
|
|
RU2342388C2
(ru)
|
2002-11-22 |
2008-12-27 |
Джапан Тобакко Инк. |
Конденсированные бициклические азотсодержащие гетероциклы, обладающие dgat ингибирующим действием
|
|
PL376925A1
(pl)
|
2002-11-27 |
2006-01-09 |
Incyte Corporation |
Pochodne 3-aminopirolidyny jako modulatory receptorów chemokiny
|
|
JPWO2004069828A1
(ja)
|
2003-02-04 |
2006-05-25 |
三菱ウェルファーマ株式会社 |
ピペリジン化合物およびその医薬用途
|
|
EP1647553A4
(en)
|
2003-07-17 |
2008-12-31 |
Astellas Pharma Inc |
2-ACYLAMINOTHIAZOL DERIVATIVE OR SALT THEREOF
|
|
US20070078120A1
(en)
|
2003-10-21 |
2007-04-05 |
Hitoshi Ban |
Novel piperidine derivative
|
|
CN1946402A
(zh)
|
2004-02-05 |
2007-04-11 |
先灵公司 |
用作ccr3拮抗剂的哌啶衍生物
|
|
KR100863854B1
(ko)
|
2004-02-10 |
2008-10-15 |
에프. 호프만-라 로슈 아게 |
케모카인 ｃｃｒ5 수용체 조절제
|
|
US7504424B2
(en)
|
2004-07-16 |
2009-03-17 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
US7488745B2
(en)
|
2004-07-16 |
2009-02-10 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
US7786141B2
(en)
|
2004-08-19 |
2010-08-31 |
Vertex Pharmaceuticals Incorporated |
Dihydrospiroindene modulators of muscarinic receptors
|
|
JP2008521821A
(ja)
|
2004-11-29 |
2008-06-26 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ムスカリン受容体のモジュレーター
|
|
JP4774995B2
(ja)
|
2005-01-12 |
2011-09-21 |
アステラス製薬株式会社 |
アシルアミノチアゾール誘導体を有効成分とする医薬組成物
|
|
WO2006105035A2
(en)
|
2005-03-28 |
2006-10-05 |
Vertex Pharmaceuticals Incorporated |
Muscarinic modulators
|
|
WO2006137485A1
(ja)
|
2005-06-24 |
2006-12-28 |
Toyama Chemical Co., Ltd. |
新規な含窒素複素環化合物およびその塩
|
|
JP2009521483A
(ja)
|
2005-12-22 |
2009-06-04 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ムスカリン受容体のモジュレーター
|
|
TW200801008A
(en)
|
2005-12-29 |
2008-01-01 |
Abbott Lab |
Protein kinase inhibitors
|
|
AU2007221214A1
(en)
|
2006-02-22 |
2007-09-07 |
Vertex Pharmaceuticals Incorporated |
Modulators of muscarinic receptors
|
|
EP1987034B1
(en)
|
2006-02-22 |
2011-07-20 |
Vertex Pharmceuticals Incorporated |
Spiro condensed piperidines as modulators of muscarinic receptors
|
|
AU2007284548A1
(en)
|
2006-08-15 |
2008-02-21 |
Vertex Pharmaceuticals Incorporated |
Modulators of muscarinic receptors
|
|
JP2010513357A
(ja)
|
2006-12-22 |
2010-04-30 |
ノバルティス アーゲー |
Ｄｐｐ−ｉｖ阻害剤としての１−アミノメチル−１−フェニル−シクロヘキサン誘導体
|
|
WO2008117229A1
(en)
|
2007-03-23 |
2008-10-02 |
Ranbaxy Laboratories Limited |
Muscarinic receptor antagonists
|
|
US8119661B2
(en)
|
2007-09-11 |
2012-02-21 |
Astrazeneca Ab |
Piperidine derivatives and their use as muscarinic receptor modulators
|
|
JP5564033B2
(ja)
|
2008-03-27 |
2014-07-30 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ヒストンデアセチラーゼの新規インヒビターとしてのアザ−ビシクロヘキシル置換インドリルアルキルアミノ誘導体
|
|
AU2009309988A1
(en)
|
2008-10-29 |
2010-05-06 |
Grunenthal Gmbh |
Substituted spiroamines
|
|
DK2379525T3
(en)
|
2008-12-19 |
2015-10-19 |
Boehringer Ingelheim Int |
Cyclic pyrimidin-4-carboxamides, as CCR2 receptor antagonists for the treatment of inflammation, asthma and COPD
|
|
NZ595432A
(en)
|
2009-04-17 |
2013-12-20 |
Janssen Pharmaceutica Nv |
4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
|
|
FR2945531A1
(fr)
|
2009-05-12 |
2010-11-19 |
Sanofi Aventis |
Derives de 7-aza-spiro°3,5!nonane-7-carboxylates, leur preparation et leur application en therapeutique
|
|
WO2011112825A2
(en)
|
2010-03-10 |
2011-09-15 |
Vanderbilt University |
Heterocyclyl-azabicyclo[3.2.1]octane analogs as selective m1 agonists and methods of making and using same
|
|
JP2013525370A
(ja)
|
2010-04-22 |
2013-06-20 |
ヤンセン ファーマシューティカ エヌ．ベー． |
ケトヘキソキナーゼ阻害剤として有用なインダゾール化合物
|
|
EP2563127A4
(en)
|
2010-04-27 |
2013-11-06 |
Merck Sharp & Dohme |
PROLYLCARBOXYPEPTIDASE INHIBITORS
|
|
WO2011143057A1
(en)
|
2010-05-11 |
2011-11-17 |
Merck Sharp & Dohme Corp. |
Novel prolylcarboxypeptidase inhibitors
|
|
EP2576520A1
(en)
|
2010-05-28 |
2013-04-10 |
GE Healthcare UK Limited |
Radiolabeled compounds and methods thereof
|
|
BR112013006344A2
(pt)
|
2010-09-17 |
2016-06-21 |
Array Biopharma Inc |
lactamas substituídas por piperdinila como moduladores de gpr119, composição farmacêutica as compreendendo, uso e processso para preparação das mesmas
|
|
EP2685828A4
(en)
|
2011-03-17 |
2014-08-13 |
Merck Sharp & Dohme |
SUBSTITUTED 3-AZABICYCLO [3,1,0-] HEXAN DERIVATIVES AS CCR2 ANTAGONISTS
|
|
JP2013010719A
(ja)
|
2011-06-30 |
2013-01-17 |
Dainippon Sumitomo Pharma Co Ltd |
ベンズイミダゾロンおよびオキシインドール誘導体ならびにそれらの医薬用途
|
|
CN104039321B
(zh)
|
2011-11-18 |
2017-02-22 |
赫普泰雅治疗有限公司 |
药物化合物
|
|
DK2897948T3
(en)
|
2012-09-18 |
2016-12-05 |
Heptares Therapeutics Ltd |
BICYCLIC AZA RELATIONS AS MUSCARIN M1 RECEPTOR AGONISTS
|
|
CN105189482A
(zh)
|
2013-02-07 |
2015-12-23 |
武田药品工业株式会社 |
作为毒蕈碱m4受体激动剂的哌啶-1-基羧酸酯和氮杂卓-1-基羧酸酯
|
|
EP3102568B1
(en)
|
2014-02-06 |
2018-06-27 |
Heptares Therapeutics Limited |
Bicyclic aza compounds as muscarinic m1 receptor agonists.
|
|
GB201404922D0
(en)
|
2014-03-19 |
2014-04-30 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
PL3265459T3
(pl)
|
2015-02-13 |
2019-09-30 |
Suven Life Sciences Limited |
Związki amidowe jako agoniści receptora 5-HT4
|
|
GB201504675D0
(en)
|
2015-03-19 |
2015-05-06 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
GB201513742D0
(en)
|
2015-08-03 |
2015-09-16 |
Heptares Therapeutics Ltd |
Muscarinic agonists
|
|
GB201513743D0
(en)
|
2015-08-03 |
2015-09-16 |
Heptares Therapeutics Ltd |
Muscarinic agonists
|
|
GB201513740D0
(en)
|
2015-08-03 |
2015-09-16 |
Heptares Therapeutics Ltd |
Muscarinic agonist
|
|
GB201519352D0
(en)
|
2015-11-02 |
2015-12-16 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
GB201617454D0
(en)
*
|
2016-10-14 |
2016-11-30 |
Heptares Therapeutics Limited |
Pharmaceutical compounds
|
|
US10259787B2
(en)
|
2016-10-14 |
2019-04-16 |
Heptares Therapeutics Limited |
Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists
|
|
GB201709652D0
(en)
*
|
2017-06-16 |
2017-08-02 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
TW201922758A
(zh)
|
2017-10-24 |
2019-06-16 |
美商歐樂根公司 |
烯胺及烯胺的非鏡像選擇性還原
|
|
GB201810239D0
(en)
|
2018-06-22 |
2018-08-08 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
GB201810245D0
(en)
|
2018-06-22 |
2018-08-08 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
GB201819960D0
(en)
|
2018-12-07 |
2019-01-23 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
GB201819961D0
(en)
|
2018-12-07 |
2019-01-23 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
GB202020191D0
(en)
|
2020-12-18 |
2021-02-03 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
GB202103211D0
(en)
|
2021-03-08 |
2021-04-21 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds for use in therapy
|